BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 25913517)

  • 1. Hydrogen sulfide and cardioprotection--Mechanistic insights and clinical translatability.
    Salloum FN
    Pharmacol Ther; 2015 Aug; 152():11-7. PubMed ID: 25913517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective Actions of H2S in Acute Myocardial Infarction and Heart Failure.
    Donnarumma E; Trivedi RK; Lefer DJ
    Compr Physiol; 2017 Mar; 7(2):583-602. PubMed ID: 28333381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardioprotective potential of hydrogen sulfide in myocardial ischemia/reperfusion injury (review).
    Dongó E; Hornyák I; Benko Z; Kiss L
    Acta Physiol Hung; 2011 Dec; 98(4):369-81. PubMed ID: 22173019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen sulfide-mediated cardioprotection: mechanisms and therapeutic potential.
    Lavu M; Bhushan S; Lefer DJ
    Clin Sci (Lond); 2011 Mar; 120(6):219-29. PubMed ID: 21126235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Hydrogen Sulfide and H2S-donors in Myocardial Protection Against Ischemia/Reperfusion Injury.
    Citi V; Piragine E; Testai L; Breschi MC; Calderone V; Martelli A
    Curr Med Chem; 2018; 25(34):4380-4401. PubMed ID: 29436990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor heart preservation with a novel long-term and slow-releasing hydrogen sulfide system.
    Sun X; Wang W; Dai J; Huang J; Shi M; Chu X; Wang F; Guo C; Wang C; Pang L; Wang Y
    Nitric Oxide; 2018 Dec; 81():1-10. PubMed ID: 30217578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cardioprotective Effects of Hydrogen Sulfide in Heart Diseases: From Molecular Mechanisms to Therapeutic Potential.
    Shen Y; Shen Z; Luo S; Guo W; Zhu YZ
    Oxid Med Cell Longev; 2015; 2015():925167. PubMed ID: 26078822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen sulfide as a potent cardiovascular protective agent.
    Yu XH; Cui LB; Wu K; Zheng XL; Cayabyab FS; Chen ZW; Tang CK
    Clin Chim Acta; 2014 Nov; 437():78-87. PubMed ID: 25058799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of exogenous H2S in recovery of cardioprotection from ischemic post-conditioning via increase of autophagy in the aged hearts.
    Chen J; Gao J; Sun W; Li L; Wang Y; Bai S; Li X; Wang R; Wu L; Li H; Xu C
    Int J Cardiol; 2016 Oct; 220():681-92. PubMed ID: 27393850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen sulfide in pharmacology and medicine--An update.
    Bełtowski J
    Pharmacol Rep; 2015 Jun; 67(3):647-58. PubMed ID: 25933982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat.
    Sivarajah A; McDonald MC; Thiemermann C
    Shock; 2006 Aug; 26(2):154-61. PubMed ID: 16878023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen sulfide improves cardiomyocytes electrical remodeling post ischemia/reperfusion injury in rats.
    Sun YG; Wang XY; Chen X; Shen CX; Li YG
    Int J Clin Exp Pathol; 2015; 8(1):474-81. PubMed ID: 25755736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effects of hydrogen sulfide in attenuating myocardial ischemia‑reperfusion injury (Review).
    Wu D; Gu Y; Zhu D
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34726247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis.
    Xu S; Liu Z; Liu P
    Int J Cardiol; 2014 Mar; 172(2):313-7. PubMed ID: 24491853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherosclerosis and the Hydrogen Sulfide Signaling Pathway - Therapeutic Approaches to Disease Prevention.
    Wang ZJ; Wu J; Guo W; Zhu YZ
    Cell Physiol Biochem; 2017; 42(3):859-875. PubMed ID: 28641276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen Sulfide as a Potential Alternative for the Treatment of Myocardial Fibrosis.
    Kang SC; Sohn EH; Lee SR
    Oxid Med Cell Longev; 2020; 2020():4105382. PubMed ID: 32064023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discoveries of hydrogen sulfide as a novel cardiovascular therapeutic.
    Barr LA; Calvert JW
    Circ J; 2014; 78(9):2111-8. PubMed ID: 25131384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous hydrogen sulfide postconditioning protects isolated rat hearts against ischemia-reperfusion injury.
    Ji Y; Pang QF; Xu G; Wang L; Wang JK; Zeng YM
    Eur J Pharmacol; 2008 Jun; 587(1-3):1-7. PubMed ID: 18468595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diallyl trisulfide protects against high glucose-induced cardiac apoptosis by stimulating the production of cystathionine gamma-lyase-derived hydrogen sulfide.
    Tsai CY; Wen SY; Shibu MA; Yang YC; Peng H; Wang B; Wei YM; Chang HY; Lee CY; Huang CY; Kuo WW
    Int J Cardiol; 2015 Sep; 195():300-10. PubMed ID: 26056963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen sulfide in renal physiology, disease and transplantation--the smell of renal protection.
    Koning AM; Frenay AR; Leuvenink HG; van Goor H
    Nitric Oxide; 2015 Apr; 46():37-49. PubMed ID: 25656225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.